Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Other Non-Current Assets (2019 - 2024)

Viemed Healthcare filings provide 6 years of Other Non-Current Assets readings, the most recent being $887000.0 for Q1 2024.

  • On a quarterly basis, Other Non-Current Assets fell 44.42% to $887000.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $887000.0, a 44.42% decrease, with the full-year FY2023 number at $887000.0, down 44.21% from a year prior.
  • Other Non-Current Assets hit $887000.0 in Q1 2024 for Viemed Healthcare, roughly flat from $887000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.3 million in Q3 2022 to a low of $861000.0 in Q1 2021.
  • Median Other Non-Current Assets over the past 5 years was $887000.0 (2023), compared with a mean of $1.1 million.
  • Biggest five-year swings in Other Non-Current Assets: surged 167.25% in 2022 and later crashed 61.45% in 2023.
  • Viemed Healthcare's Other Non-Current Assets stood at $863000.0 in 2020, then fell by 0.12% to $862000.0 in 2021, then skyrocketed by 84.45% to $1.6 million in 2022, then tumbled by 44.21% to $887000.0 in 2023, then changed by 0.0% to $887000.0 in 2024.
  • The last three reported values for Other Non-Current Assets were $887000.0 (Q1 2024), $887000.0 (Q4 2023), and $887000.0 (Q3 2023) per Business Quant data.